Welcome to our dedicated page for Taylor Devices SEC filings (Ticker: TAYD), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Taylor Devices, Inc. (TAYD) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. Taylor Devices is a manufacturing company that designs, develops, manufactures and markets shock absorption, rate control and energy storage devices for vehicles, machinery, equipment and structures, and its filings offer detailed insight into this business.
Investors can use this page to locate annual reports on Form 10‑K and quarterly reports on Form 10‑Q, which typically contain information about Taylor Devices’ markets in Aerospace/Defense, Structural Construction and Industrial segments, along with discussions of sales trends, order backlog and risk factors. Current reports on Form 8‑K, such as the October 2025 filing describing shareholder approval of the 2025 Stock Option Plan and other annual meeting outcomes, document material events including equity compensation plans, auditor ratification and voting results.
The page also surfaces proxy statements (DEF 14A), where Taylor Devices outlines governance matters like its classified board structure, director elections and proposals such as the Taylor Devices, Inc. 2025 Stock Option Plan. These documents provide context on how the company’s board oversees strategy and compensation.
Stock Titan enhances these filings with AI‑powered summaries that explain key points in plain language, helping users quickly understand lengthy documents without reading every page. Real‑time updates from EDGAR ensure that new 10‑K, 10‑Q, 8‑K and proxy filings appear promptly, and insider‑related forms such as Form 4 can be reviewed to monitor transactions by directors and officers. This makes the TAYD filings page a practical starting point for analyzing Taylor Devices’ regulatory history and ongoing disclosure practices.
Taylor Devices, Inc. director Robert Michael Carey reported selling a total of 5,000 shares of Common Stock in open-market transactions. On April 28, 2026, he executed two separate sales at weighted average prices of $57.27 and $55.52 per share.
Footnotes explain that each reported price is a weighted average for multiple trades completed within narrow ranges around those prices, and that detailed price-by-trade information is available upon request. The transactions were reported as direct ownership sales.
TAYD submitted a Form 144 notice regarding the proposed sale of Common shares. The filing lists a quantity of 5,000 and an associated numeric value of 285,600.00, references Nasdaq, and records two prior option exercises dated 10/28/2024 that converted 3,989 and 3,732 shares from equity compensation awards dated 04/18/2022 and 04/22/2021.
TAYLOR DEVICES, INC. Chief Executive Officer Timothy John Sopko received a grant of stock options covering 7,000 shares of Common Stock as compensation. The options have an exercise price of $56.43 per share and expire on April 18, 2036. Following this grant, he holds 7,000 stock options directly.
TAYLOR DEVICES, INC. director Robert Michael Carey received a grant of stock options representing 7,000 shares of common stock. These options were awarded at an exercise price of 56.43 per share and are exercisable into 7,000 shares of common stock. Following this grant, Carey holds 7,000 derivative securities linked to the company’s stock, with an expiration date of April 18, 2036.
TAYLOR DEVICES, INC. Chief Financial Officer Paul Murray Heary reported a compensation-related equity award. He received a grant of stock options covering 7,000 shares of common stock, giving him the right to buy those shares at an exercise price of $56.43 per share.
The options were granted on April 18, 2026 and are scheduled to expire on April 18, 2036. The filing shows no open-market buying or selling of common stock; instead, it records this grant/award acquisition of derivative securities, leaving him with 7,000 stock options after the transaction.
TAYLOR DEVICES, INC. director John Burgess received a grant of stock options on April 18, 2026. He was awarded options for 7,000 shares of common stock with an exercise price of $56.43 per share. After this compensation grant, he holds options for 7,000 shares directly.
Taylor Devices, Inc. director Armenat Fritz Eric reported a compensation-related grant of stock options. He acquired 7,000 Stock Options (Right to Buy) for the company’s common stock on April 18, 2026.
The options carry an exercise price of $56.43 per share and are scheduled to expire on April 18, 2036. After this award, he holds stock options for 7,000 underlying common shares directly.
TAYLOR DEVICES, INC. director John Burgess exercised stock options to acquire 5,000 shares of common stock at an exercise price of $16.40 per share on April 13, 2026. As part of the same event, 1,574 shares of common stock were withheld to satisfy the exercise price or related tax liability, which is a non-market, tax-withholding disposition rather than an open-market sale. Following these transactions, Burgess directly owns 43,426 shares of Taylor Devices common stock.
Taylor Devices, Inc. reported higher sales and earnings for the nine months ended February 28, 2026. Net revenue grew to $32.7 million from $30.7 million, while net income rose to $6.7 million from $5.7 million, and earnings per share increased to $2.12 from $1.83.
Gross margin dipped slightly to 44% from 45% as cost of goods sold rose faster than revenue, but lower selling, general and administrative expenses helped lift operating income to $6.8 million from $5.9 million. Revenue mix shifted further toward aerospace/defense customers, which represented 66% of nine‑month sales, with structural and industrial customers lower.
The company’s balance sheet remained strong, with cash and cash equivalents of $2.5 million and short‑term investments of $39.2 million. Inventory and maintenance inventory together declined about 10% year over year, while order backlog fell from $33.3 million to $20.8 million, which management attributes to timing of backlog conversion to revenue.
Wax Asset Management, LLC filed an amended ownership report showing it beneficially owns 297,666 shares of Taylor Devices Inc common stock, representing 9.4% of the outstanding class as of 12/31/2025. Wax Asset Management has sole power to vote and dispose of all these shares.
The firm states the shares were acquired and are held in the ordinary course of business, and not with the purpose or effect of changing or influencing control of Taylor Devices. The position is not held on behalf of other parties and is not part of any reported group.